-
Cardinal Health Earnings Preview: Analysts Expect Rising Revenue, EPS
Monday, August 1, 2011 - 10:30am | 586Cardinal Health (NYSE: CAH) announces its next round of earnings this Thursday, August 4, 2011. Get the latest predictions in Benzinga's essential guide to the company's fourth quarter earnings report. Earnings and Revenue: Ahead of the company's earnings announcement, analysts are expecting...
-
Bard Announces Retirement of Todd C. Schermerhorn, Senior Vice President and Chief Financial Officer
Monday, August 1, 2011 - 9:06am | 56C. R. Bard, Inc. (NYSE: BCR) today announced that Todd C. Schermerhorn, senior vice president and chief financial officer, will retire after a transition period that is expected to run through August 2012. Mr. Schermerhorn will continue to serve as CFO during this period until his successor is...
-
Alphatec Holdings, Inc. Names Leslie H. Cross Chairman of the Board of Directors
Monday, August 1, 2011 - 9:05am | 68Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced that...
-
Medtronic Receives FDA Approval for Advisa DR MRI SureScan Pacing System Clinical Trial
Monday, August 1, 2011 - 9:04am | 154Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration approval for its Investigational Device Exemption application and pivotal clinical trial protocol to begin evaluating Advisa DR MRI™ SureScan® pacing system. FDA approval of the Advisa MRI System Study protocol enables...
-
Covidien Receives FDA Approval for Morphine Sulfate Oral Solution
Monday, August 1, 2011 - 8:09am | 62Covidien (NYSE: COV) today announced that the U.S. Food and Drug Administration recently granted approval to the company's Mallinckrodt business for morphine sulfate oral solution, used to relieve moderate to severe acute and chronic pain in opioid-tolerant patients. The solution will be...
-
Stocks to Watch for Monday 8/01/2011: Fresh 52 Week Highs and Lows
Sunday, July 31, 2011 - 10:55pm | 3407Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and exit/entry points become more clearly defined. The following stocks hit new 52-week highs in Friday's trading session (listed from highest total volume to...
-
Friday's Put/Call Ratio Leaders
Friday, July 29, 2011 - 1:04pm | 78Here are today's Put/Call Ratio leaders… 1. Cadence Design Systems (NASDAQ: CDNS) 10,247 puts, 187 calls 2. Calevision Systems (NYSE: CVC) 7,162 puts, 160 calls 3. Lexmark International (NYSE: LXK) 6,344 puts, 180 calls 4. Life Technologies (NASDAQ: LIFE) 4,770 puts, 226 calls 5. Thoratec Corp. (...
-
WorldHeart Will End Its Levacor VAD Program; Will Focus on Developing Its Next-Generation MiFlow Miniature Ventricular Assist Device
Friday, July 29, 2011 - 12:02pm | 43World Heart Corporatio (Nasdaq: WHRT) announced today that it will cease its efforts to commercialize the Levacor ventricular assist device technology and will focus its resources on developing and commercializing its smaller, next-generation MiFlow VAD.
-
Jefferies Revises EPS Estimates On WMGI
Friday, July 29, 2011 - 10:37am | 43According to Jefferies, Wright Medical Group (NASDAQ: WMGI), EPS estimates have been revised. Jefferies decreased EPS estimates from $0.77 to $0.76 for FY11. PT is set to $16 and rating is set to Hold. WMGI closed yesterday at $14.47.
-
Piper Jaffray Reiterates PT And Rating On Wright Medical
Friday, July 29, 2011 - 10:30am | 30According to Piper Jaffray, Wright Medical (NASDAQ: WMGI) is reiterating their PT of $18 and their rating of Overweight. WMGI closed yesterday at $14.47.
-
Duncan-Williams Reviews 2Q on Wright Medical Group
Friday, July 29, 2011 - 10:19am | 137Duncan-Williams has published a research report on Wright Medical Group (NASDAQ: WMGI) commenting on the 2Q11 release of earnings results. In the report, Duncan-Williams wrote, "WMGI reported Q2:11 revenue and adjusted EPS of $132.5 million and $0.23, below our revenue estimate of $134.9 million...
-
Earnings Preview: Allergan's EPS, Revenue Expected to Rise
Friday, July 29, 2011 - 10:05am | 582Allergan (NYSE: AGN) unveils its next round of earnings this Wednesday, August 3, 2011. Here is Benzinga's everything-that-matters guide for this Wednesday's second quarter earnings announcement. Earnings and Revenue: Ahead of the company's earnings announcement, analysts are expecting a...
-
Morgan Keegan Reports Good Quarter For Boston Scientific
Friday, July 29, 2011 - 9:32am | 88According to Morgan Keegan, Boston Scientific (NYSE: BSX) had a good quarter. Morgan Keegan said that the quarter was good coming in at the high end or beating consensus, but the story still is that the company is meeting its long-term strategic plan's milestones. “Third quarter estimates lowered...
-
Pre-Market Losers
Friday, July 29, 2011 - 9:28am | 175Quantum (NYSE: QTM) is trading down 11% after being cut to Neutral by Sterne Agee. Netgear (NASDAQ: NTGR) is trading down over 9% after quarterly results yesterday. Ancestry.com (NASDAQ: ACOM) is trading down over 7% after reporting earnings yesterday. Arch Coal (NYSE: ACI) is trading down over 7%...
-
ZOLL Medical up 13% Pre-Market on Upbeat Earnings
Friday, July 29, 2011 - 9:16am | 43ZOLL Medical (NASDAQ: ZOLL) is up 13% pre-market on the upbeat earnings. The company reported yesterday Q2 EPS $0.42 vs $0.35 Est; Revenues $136.2M vs $129.97M Est. ZOLL Medical is currently trading at $62.29 pre-market, a gain of $6.90 or 12.46%.